COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.
about
rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina PatientsAcetylsalicylic Acid resistance in patients with type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease.Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.Evaluation of low-dose aspirin for primary prevention of ischemic stroke among patients with diabetes: a retrospective cohort study.Thromboxane synthase deficiency improves insulin action and attenuates adipose tissue fibrosis.The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with AspirinPrevalence of and risk factors for aspirin resistance in elderly patients with coronary artery diseaseCelecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes RegisterEstablishing a predictive model for aspirin resistance in elderly Chinese patients with chronic cardiovascular diseaseAdvances in monitoring of aspirin therapy.Overcoming aspirin treatment failure in diabetes.Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms.Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals.
P2860
Q33561276-1234D59E-C3E1-44A7-83D5-C9C981164B0BQ33722562-69C92E49-5FD5-4832-8356-1D0C9594260AQ34109255-564BA909-12BA-4E17-94B4-1809501E942FQ34635535-8BA10855-F333-4B1C-A001-D727645A2C21Q35136444-08F83629-F4F1-4099-913F-E869406BE148Q35572938-658B6612-2524-40BB-BB3F-F67EE8DA55E0Q35684231-E90F5D8A-50D8-4269-83ED-FED3829E9921Q36769860-63C37AF0-8407-4719-9CF7-291C2C615F9AQ36802113-E9CD7AD1-BC5F-4388-8803-2E5D0425A15BQ36809851-8938B597-8449-4123-A661-EC68FF374B34Q37174269-BE382C1D-651E-4323-AD26-7108D85E859FQ38032895-E9752C1C-C747-4D51-9280-DD456F3631A8Q38055245-611DA0CA-BD0A-4812-AFA0-C95C1F1BE14AQ39658839-6B87CA4C-0C52-4F8A-9FB2-4496F1C23291Q41313656-67F285BA-3360-4B6C-A8FB-D4C5A98716B1Q45180360-DA9362D7-29DB-4545-866D-EEC2A525C6EF
P2860
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
COX-1 sensitivity and thrombox ...... der chronic aspirin treatment.
@en
COX-1 sensitivity and thrombox ...... der chronic aspirin treatment.
@nl
type
label
COX-1 sensitivity and thrombox ...... der chronic aspirin treatment.
@en
COX-1 sensitivity and thrombox ...... der chronic aspirin treatment.
@nl
prefLabel
COX-1 sensitivity and thrombox ...... der chronic aspirin treatment.
@en
COX-1 sensitivity and thrombox ...... der chronic aspirin treatment.
@nl
P2093
P2860
P50
P356
P1476
COX-1 sensitivity and thrombox ...... nder chronic aspirin treatment
@en
P2093
Andrea Leo
Dario Pitocco
Elisabetta Trifirò
Fabio M Pulcinelli
Filippo Crea
Giovanni Ghirlanda
Livia Di Renzo
Simona Giubilato
Teresa Mattiello
P2860
P304
P356
10.1093/EURHEARTJ/EHP097
P577
2009-04-03T00:00:00Z